Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Labelling for life
25 January, 2024
We don’t often think of labelling as a risky behaviour, but...
> read more

The shifting roles of CROs 25 January, 2024 The dial has been shifting for some time now on how much research and development work is carried out in-house by pharmaceutical companies. While outsourcing in the industry was...

Oncology's data puzzle 25 January, 2024 Oncology trials generate huge volumes of data from many different sources, and they do so over long periods of time. The payoff of demonstrating an effective therapy for cancer can...

Innovations and hurdles 25 January, 2024 The discovery and development of CAR T-cell therapies will go down in the annals of medical history. But while remarkably effective against a range of cancers, these advanced...

Centralised submission 25 January, 2024 The change from the Clinical Trials Directive to the Clinical Trials Regulation in Europe has been long and slow, but now that the new regime is in place there is one burning question...

Innovation in inhalation 29 December, 2023 Blue and brown inhalers have become synonymous with asthma, but inhaling doses of medication is something we might see more of as drug developers look at inhalation as a strategy to...

Polysorbates and their alternatives 29 December, 2023 Unlike small-molecule drugs – which are typically chemically synthesised – biologics are large, complex molecules derived from living organisms. The downside of this is that these...

A green future for peptides 29 December, 2023 The use of peptides has been growing at pace during the past couple of decades, owing to their high likelihood of regulatory approval and probability of success in clinical trials....

Air or sea? 29 December, 2023 The majority of the world’s pharmaceuticals are transported by sea freight, owing to its substantially lower cost. The predominant reason for using air freight instead is urgency, but...

The viscosity problem 29 December, 2023 It’s no surprise that the physical characteristics of an injectable substance will have a bearing on how it functions inside the body. But exactly what those effects are may not be...

The right selection 29 December, 2023 A large portion of pharmaceutical manufacturing happens outside of the premises of the companies who brand and sell drug products. According to some sources, it could be as high...

Sustainability in mind 29 December, 2023 Reaching carbon neutrality by 2040 will require a lot more of pharmaceutical companies than reducing CO2 emissions, water and electricity. Coordinated effort is required...

Pharma 4.0 29 December, 2023 Tools that take advantage of advances in AI and machine learning, alongside other burgeoning technologies, are often marked with a ‘4.0’ suffix to denote that it’s part of the...

How well-written clinical study protocols get drugs to patients faster 31 October, 2023 In the world of drug development and approval, time is of the essence. But beginning the process with a poorly written protocol will only impede teams before a study has even begun....

Blind faith 31 October, 2023 Trial designs can vary signifi cantly when it comes to how much knowledge the personnel and participants involved have. But to what end does this serve? Furthermore, what’s required...

Lessons in logistics 31 October, 2023 Even before the pandemic, researchers were moving away from in-person clinical trials and towards digital alternatives, and the trend was only escalated by the required lockdowns...

Augmented with AI 31 October, 2023 The process of organising and running a clinical trial comes with several challenges, and a significant portion of the cost can be attributed to the operational conduct of the trial....

A hot-headed decision 31 October, 2023 The process of transporting pharmaceutical products to clinical trials has many moving parts, all of which bring potential risk. Between the pharma companies, their logistics partners...

Central intelligence 31 October, 2023 Central laboratories have become a crucial part of running global and multi-regional clinical trials. Drug developers place a great deal of trust in these partner organisations,...

Comparator Sourcing 31 October, 2023 Comparator drugs are a crucial part of clinical trials everywhere; helping researchers understand exactly how their inventions fare against the competition, or even when drugs can...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.